Simplify Logo

Full-Time

Lead – Patent Agent

Confirmed live in the last 24 hours

Amylyx Pharmaceuticals

Amylyx Pharmaceuticals

201-500 employees

Develops treatments for neurodegenerative diseases

Social Impact
Biotechnology
Healthcare

Senior, Expert

Remote in USA

Category
Intellectual Property (IP)
Legal & Compliance
Requirements
  • Must be a registered patent agent in good standing with United States Patent and Trademark Office
  • Ph.D. in chemistry, biochemistry, or other life-science related field, or M.S. with relevant technical life-science industry experience
  • 5+ years patent prosecution experience with significant expertise in drafting and prosecuting patents related to small-molecule pharmaceuticals
  • Expertise in conducting patentability and patent freedom-to-operate searches and analyses on small molecule therapeutics
  • Experience managing high-volume global patent docket
  • Effective and proactive communicator
Responsibilities
  • Draft and prosecute patent applications and manage day-to-day patent prosecution activities and deadlines, including drafting office action responses, formal documents, and other filings
  • Partner with external patent counsel toward cost-effective management of global patent prosecution activities in strategic alignment with business priorities and goals
  • Proactively track R&D, clinical, and manufacturing activities toward invention harvesting and developing patent strategy to protect Amylyx technology
  • Proactively track and review publication activity and public disclosures to ensure alignment with patent strategy
  • Perform patentability, freedom-to-operate, and patent due diligence analyses
  • Develop and implement internal processes toward cost-effective management of global patent portfolio
Amylyx Pharmaceuticals

Amylyx Pharmaceuticals

View

Amylyx Pharmaceuticals develops treatments for neurodegenerative diseases, focusing on conditions like Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's Disease (ALZ). Their main product, AMX0035, is currently undergoing clinical trials to assess its effectiveness. The CENTAUR ALS trial showed promising results for ALS patients, using a randomized, double-blind, placebo-controlled design to ensure reliable outcomes. They are also conducting the PEGASUS trial to evaluate AMX0035's safety and effectiveness in Alzheimer's patients. Unlike many competitors, Amylyx emphasizes community engagement and awareness campaigns, such as ALS Awareness Month, to educate the public and foster support for those affected by these diseases. The company's goal is to bring effective therapies to market that improve patient outcomes.

Company Stage

IPO

Total Funding

$548.9M

Headquarters

Cambridge, Massachusetts

Founded

2013

Growth & Insights
Headcount

6 month growth

-5%

1 year growth

8%

2 year growth

58%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful acquisition of Phase 3-ready avexitide from Eiger could diversify Amylyx's pipeline and open new revenue streams.
  • Interim data from the Phase 2 HELIOS trial shows promising results for AMX0035 in treating Wolfram syndrome, indicating potential for broader applications.
  • The appointment of experienced professionals like Dr. Bernhardt Zeiher to the Board of Directors strengthens the company's leadership and strategic direction.

What critics are saying

  • The failure of the Phase III PHOENIX trial and subsequent market withdrawal of Relyvrio raises concerns about the efficacy of Amylyx's treatments.
  • A significant workforce reduction by 70% under a restructuring plan could impact company morale and operational efficiency.

What makes Amylyx Pharmaceuticals unique

  • Amylyx Pharmaceuticals focuses on neurodegenerative diseases like ALS and Alzheimer's, setting it apart from competitors with broader therapeutic areas.
  • The company's flagship product, AMX0035, has shown significant treatment benefits in rigorous clinical trials, including the CENTAUR ALS trial, which is a strong validation of its efficacy.
  • Amylyx's commitment to community engagement and awareness campaigns, such as ALS Awareness Month, enhances its brand and builds a supportive community around its cause.